“Artemisinic acid exhibits antitumor activity in MCF-7 breast cancer cells through the inhibition of angiogenesis, VEGF, m-TOR and AKT signalling pathways”, Bangladesh J Pharmacol, vol. 11, no. 3, pp. 691–696, Jul. 2016, doi: 10.3329/bjp.v11i3.26512.